JP2003528614A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003528614A5 JP2003528614A5 JP2001570795A JP2001570795A JP2003528614A5 JP 2003528614 A5 JP2003528614 A5 JP 2003528614A5 JP 2001570795 A JP2001570795 A JP 2001570795A JP 2001570795 A JP2001570795 A JP 2001570795A JP 2003528614 A5 JP2003528614 A5 JP 2003528614A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- processing component
- antigenic polypeptide
- processing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000039446 nucleic acids Human genes 0.000 description 16
- 108020004707 nucleic acids Proteins 0.000 description 16
- 150000007523 nucleic acids Chemical class 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 15
- 230000000890 antigenic effect Effects 0.000 description 11
- 229920001184 polypeptide Polymers 0.000 description 11
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000724675 Hepatitis E virus Species 0.000 description 2
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940023146 nucleic acid vaccine Drugs 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU6616 | 2000-03-31 | ||
| AUPQ6616A AUPQ661600A0 (en) | 2000-03-31 | 2000-03-31 | A nucleic acid construct and methods related thereto |
| PCT/AU2001/000353 WO2001073078A1 (en) | 2000-03-31 | 2001-03-30 | A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003528614A JP2003528614A (ja) | 2003-09-30 |
| JP2003528614A5 true JP2003528614A5 (enExample) | 2008-05-15 |
Family
ID=3820712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570795A Withdrawn JP2003528614A (ja) | 2000-03-31 | 2001-03-30 | 肝炎ウイルスのｏｒｆ２のｎ末端領域に由来するプロセシング成分および抗原性ポリペプチドをコードする核酸構築物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7341723B2 (enExample) |
| EP (1) | EP1274851B1 (enExample) |
| JP (1) | JP2003528614A (enExample) |
| KR (1) | KR100768051B1 (enExample) |
| CN (1) | CN1426472A (enExample) |
| AT (1) | ATE430804T1 (enExample) |
| AU (1) | AUPQ661600A0 (enExample) |
| CA (1) | CA2407036A1 (enExample) |
| DE (1) | DE60138612D1 (enExample) |
| HK (1) | HK1052368A1 (enExample) |
| MX (1) | MXPA02009437A (enExample) |
| NZ (1) | NZ521758A (enExample) |
| WO (1) | WO2001073078A1 (enExample) |
| ZA (1) | ZA200207769B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1665528B (zh) | 2002-07-05 | 2013-05-15 | 弗利亚生物技术公司 | 佐剂病毒颗粒 |
| US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
| KR100641810B1 (ko) * | 2004-04-23 | 2006-11-06 | 주식회사 포스코건설 | 충격흡수 및 복원 가능한 중간 스프링 설치 금속재 지주 |
| EP2400982B1 (en) * | 2009-02-27 | 2016-05-11 | The Regents of The University of California | Multiple antigen delivery system using hepatitis e virus-like particle |
| US8906862B2 (en) | 2009-02-27 | 2014-12-09 | The Regents Of The University Of California | Multiple antigen delivery system using hepatitis E virus-like particle |
| US8906863B2 (en) | 2009-02-27 | 2014-12-09 | The Regents Of The University Of California | Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector |
-
2000
- 2000-03-31 AU AUPQ6616A patent/AUPQ661600A0/en not_active Abandoned
-
2001
- 2001-03-30 CN CN01808764A patent/CN1426472A/zh active Pending
- 2001-03-30 JP JP2001570795A patent/JP2003528614A/ja not_active Withdrawn
- 2001-03-30 CA CA002407036A patent/CA2407036A1/en not_active Abandoned
- 2001-03-30 EP EP01916744A patent/EP1274851B1/en not_active Expired - Lifetime
- 2001-03-30 NZ NZ521758A patent/NZ521758A/en unknown
- 2001-03-30 KR KR1020027013060A patent/KR100768051B1/ko not_active Expired - Fee Related
- 2001-03-30 AT AT01916744T patent/ATE430804T1/de not_active IP Right Cessation
- 2001-03-30 WO PCT/AU2001/000353 patent/WO2001073078A1/en not_active Ceased
- 2001-03-30 MX MXPA02009437A patent/MXPA02009437A/es unknown
- 2001-03-30 HK HK03104476.2A patent/HK1052368A1/zh unknown
- 2001-03-30 DE DE60138612T patent/DE60138612D1/de not_active Expired - Fee Related
-
2002
- 2002-09-26 ZA ZA200207769A patent/ZA200207769B/en unknown
- 2002-09-27 US US10/260,846 patent/US7341723B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019139064A (ru) | Композиции и способы для лечения цитомегаловируса | |
| JP2009523422A5 (enExample) | ||
| JP2002510494A5 (enExample) | ||
| JP2009540801A5 (enExample) | ||
| EP1018557A3 (en) | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof | |
| CA2196555A1 (en) | Vr-2332 viral nucleotide sequence and methods of use | |
| JP2019530462A5 (enExample) | ||
| JP2004502460A5 (enExample) | ||
| RU2006105498A (ru) | Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus | |
| JP2007516696A5 (enExample) | ||
| JP2003510050A5 (enExample) | ||
| SG144692A1 (en) | Antigenic proteins of shrimp white spot syndrome virus and uses thereof | |
| JP2025094154A5 (enExample) | ||
| JP2003528614A5 (enExample) | ||
| MX2025002402A (es) | Particulas tipo virus modificadas de cmv | |
| WO2003090667A3 (fr) | Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16 | |
| JP2020509770A5 (enExample) | ||
| JP2018533908A5 (enExample) | ||
| JP2003514576A5 (enExample) | ||
| MY135991A (en) | A vaccine-induced hepatits b viral strain and uses thereof | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| RU2005126236A (ru) | Фьюжн-белок для подавления цервикального рака | |
| WO2007064844A3 (en) | Anti-viral griffithsin compounds, compositions, and methods of use | |
| CA2521038A1 (en) | Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production | |
| RU2019113940A (ru) | Мозаичные вакцины от вируса ящура серотипа а |